Search by Drug Name or NDC
NDC 00078-0743-03 ILEVRO 3 mg/mL Details
ILEVRO 3 mg/mL
ILEVRO is a OPHTHALMIC SUSPENSION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is NEPAFENAC.
MedlinePlus Drug Summary
Ophthalmic nepafenac is used to treat eye pain, redness, and swelling in patients who are recovering from cataract surgery (procedure to treat clouding of the lens in the eye). Nepafenac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the production of certain natural substances that cause pain and swelling.
Related Packages: 00078-0743-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nepafenac Ophthalmic
Product Information
| NDC | 00078-0743 |
|---|---|
| Product ID | 0078-0743_436d5fa3-8223-49a8-8e65-09dac83281e3 |
| Associated GPIs | 86805050001840 |
| GCN Sequence Number | 070358 |
| GCN Sequence Number Description | nepafenac DROPS SUSP 0.3 % OPHTHALMIC |
| HIC3 | Q6P |
| HIC3 Description | EYE ANTI-INFLAMMATORY AGENTS |
| GCN | 33869 |
| HICL Sequence Number | 033195 |
| HICL Sequence Number Description | NEPAFENAC |
| Brand/Generic | Brand |
| Proprietary Name | ILEVRO |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | nepafenac |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/mL |
| Substance Name | NEPAFENAC |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA203491 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0743-03 (00078074303)
| NDC Package Code | 0078-0743-03 |
|---|---|
| Billing NDC | 00078074303 |
| Package | 1 BOTTLE in 1 CARTON (0078-0743-03) / 3 mL in 1 BOTTLE |
| Marketing Start Date | 2021-01-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 121.424 |
| Pricing Unit | ML |
| Effective Date | 2024-01-19 |
| NDC Description | ILEVRO 0.3% OPHTH DROPS |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis